Last reviewed · How we verify
NCT04454606
The New Silicone N99 Half-Piece Respirator
NA trial testing Fit test in COVID in 43 participants. Completed in 31 May 2020.
15 May 2020
Quick facts
| Lead sponsor | Bangkok Metropolitan Administration Medical College and Vajira Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 43 |
| Start date | 1 May 2020 |
| Primary completion | 15 May 2020 |
| Estimated completion | 31 May 2020 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Fit test
- Filtration Test
Conditions studied
- COVID — all drugs for COVID →
- Personal Protective Equipment — all drugs for Personal Protective Equipment →
Sponsor
Bangkok Metropolitan Administration Medical College and Vajira Hospital
Who can join
Adults 18 to 60, any sex, with COVID or Personal Protective Equipment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Filter facepiece respirator (FFR) is a critical equipment to prevent the transmission of respiratory tract infection disease especially the dreadful corona virus 2(SARs-CoV-2).The N95 mask is the prototype of high efficiency protective device and can effectively protect airborne pathogens of less than 0.3 μm by more than 95%. It is tightly fit and had high filtration capacity. The widespread pandemic of COVID-19 leads to greater requirement of FFR. A rising in demand would greatly exceed current productive capabilities and stockpiles and would almost certainly result in a robust shortage. In order to solve these problems, our team had invented a new type of half-piece respirator made from silicone and assembled with hepa or elastostatic filter . A variety of methods have been used to evaluate this new device, including qualitative fit test with Bitrex® test kit and filtration test.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04454606
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fit test
Trials testing the same drug.
- NCT04749121 — Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators · NA · completed
Other recruiting trials for COVID
Currently open trials in the same condition.
- NCT06744660 — Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test · NA · recruiting
- NCT04910269 — Outpatient Treatment With Anti-Coronavirus Immunoglobulin · Phase 3 · recruiting
- NCT04447833 — Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome · Phase 1 · active not recruiting
- NCT04351347 — The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment · Phase 2, PHASE3 · recruiting
- NCT04382846 — Novel Regimens in COVID-19 Treatment · Phase 3 · recruiting
Other Bangkok Metropolitan Administration Medical College and Vajira Hospital trials
Trials by the same sponsor.
- NCT07515092 — Virtual Reality-Based Simulation Training for Antegrade Anterior Column Acetabular Screw Placement in Orthopedic Residen · NA · enrolling by invitation
- NCT06689124 — A Randomized Study Comparing of Three Doses Nebulized Fentanyl in Older Adults · NA · active not recruiting
- NCT05716386 — Effect of Low Salt and Ckd Progression · NA · completed
- NCT05348759 — Pulmonary Function and CT Scan Finding in CKD Patients After COVID-19 Infection · completed
- NCT05280106 — Citrate Dialysate in Online Hemodialfiltration · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04454606 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bangkok Metropolitan Administration Medical College and Vajira Hospital
- Last refreshed: 1 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04454606.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing